Skip to main content
. 2022 Jan 29;107(5):1239–1246. doi: 10.1210/clinem/dgac046

Table 3.

Treatment use and types of systemic therapy (N = 621)

No. (%) Before July 2007 (N = 260) ≥ July 2007 (N = 361) P
Mitotane 421 (67.8) 166 (63.9) 255 (70.6) .07
Cytotoxic chemotherapy including targeted therapy 347 (55.9) 138 (53.1) 209 (57.9) .23
Immunotherapy 53 (8.5) 2 (0.3) 51 (8.2) < .0001